Research Study Investigating Study Medicine (NNC9204-1177) for Weight Management in People With Overweight or Obesity

NCT03308721 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

99

Enrollment

INDUSTRY

Sponsor class

Conditions

Metabolism and Nutrition Disorder
Obesity

Interventions

DRUG: NNC9204-1177 A 1.0 mg/mL
DRUG: PLACEBO

Sponsor

Novo Nordisk A/S